Prevalence of Therapeutic Inertia in the Management of Overweight and Obesity in Patients With a Diagnosis of Type 2 Diabetes Who Are Followed up by Primary Care Physicians
Obesity Science & Practice · 2026-04 · 12 (2)
DOI: 10.1002/osp4.70121 ↗Kurz gefasst
Fachartikel in der Zeitschrift Obesity Science & Practice, online erschienen am 02.03.2026. Verfasst von Pablo Aschner und 1 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Epidemiologist Hospital Universitario San Ignacio Bogotá Colombia. Die Arbeit nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Themen: Diabetes mellitus
Abstract (Originalsprache)
Introduction
Information on therapeutic inertia (TI) in weight loss in people with type 2 diabetes (T2D) is limited.
Objective
To describe the prevalence of TI in the management of overweight/obesity in people with T2D undergoing primary care program (PCP) follow‐up and weight changes according to the prescribed treatment.
Methods
A retrospective longitudinal study was conducted in patients with T2D with body mass index (BMI) ≥ 25 kg/m 2 followed by PCP. The following data were obtained from medical records at the first assessment, 6 and 12 months: anthropometric data, HbA1c, medications added according to their effect on weight, and specialist referrals (nutrition and metabolic and bariatric surgery).
Results
A total of 128 patients were included (age 65.5 ± 11.7 years, HbA1c 7.8 ± 1.7%, BMI 33.1 ± 5.7 kg/m 2 ). The mean HbA1c at the end of follow‐up was 7.4% ± 1.4%. Twenty‐five percent achieved ≥ 5% weight loss after 12 months. The proportion of patients without weight‐loss interventions increased from 59% in the first assessment to 86% and 89% after 6 and 12 months of follow‐up. Patients who lost ≥ 5% of their weight were more likely to be referred to dietary counseling at program entry (37.5% vs. 23.4%) and at 6 months (18.8% vs. 6.4%) compared to patients who gained weight. In addition, the prescription of SGLT2 inhibitors/GLP1‐receptor agonist was higher in this group at 6 months (49.3% vs. 10.7%).
Conclusions
Although there was a reduction in HbA1c, the TI for prescribing weight‐loss interventions was high. This suggests the importance of including weight loss as a therapeutic goal alongside lowering HbA1c in primary care.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Clinical Epidemiologist Hospital Universitario San Ignacio Bogotá Colombia.
- Faculty of Medicine Pontificia Universidad Javeriana Bogotá Colombia.
- Endocrinology Unit Hospital Universitario San Ignacio Bogotá Colombia.
ORCID-Profile: Pablo Aschner, Diana Henao-Carrillo
Zitieren
APA
Aschner, P., & Henao-Carrillo, D. (2026). Prevalence of Therapeutic Inertia in the Management of Overweight and Obesity in Patients With a Diagnosis of Type 2 Diabetes Who Are Followed up by Primary Care Physicians. Obesity Science & Practice, 12(2). https://doi.org/10.1002/osp4.70121
Vancouver
Aschner P, Henao-Carrillo D. Prevalence of Therapeutic Inertia in the Management of Overweight and Obesity in Patients With a Diagnosis of Type 2 Diabetes Who Are Followed up by Primary Care Physicians. Obesity Science & Practice. 2026;12(2). doi:10.1002/osp4.70121
BibTeX
@article{Aschner2026,
author = {Aschner, Pablo and Henao-Carrillo, Diana},
title = {Prevalence of Therapeutic Inertia in the Management of Overweight and Obesity in Patients With a Diagnosis of Type 2 Diabetes Who Are Followed up by Primary Care Physicians},
journal = {Obesity Science & Practice},
year = {2026},
volume = {12},
number = {2},
doi = {10.1002/osp4.70121}
}
EUVIMED